OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target
Ruixuan You, Xinglan He, Zhuotong Zeng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 75

The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics
Demetra S.M. Chatzileontiadou, Hannah Sloane, Andrea Nguyen, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 73-73
Open Access | Times Cited: 73

Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
Sally A. Clayton, Lucy MacDonald, Mariola Kurowska‐Stolarska, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59

Id2 exacerbates the development of rheumatoid arthritis by increasing IFN‐γ production in CD4+ T cells
Haoyang Sun, Jinlin Miao, Kui Zhang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1

TIGIT as a Promising Therapeutic Target in Autoimmune Diseases
Chenran Yue, Sheng Gao, Shuting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22

The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm
Robert Hoffrogge, Anna Karachunskaya, Neele Heitmann, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Th1-related transcription factors and cytokines in systemic lupus erythematosus
Yang‐Yang Tang, Dacheng Wang, You-Yue Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

E3 ubiquitin ligases STUB1/CHIP contributes to the Th17/Treg imbalance via the ubiquitination of aryl hydrocarbon receptor in rheumatoid arthritis
Wen Wang, Ting Xiang, Yachen Yang, et al.
Clinical & Experimental Immunology (2022) Vol. 209, Iss. 3, pp. 280-290
Open Access | Times Cited: 15

Citrullination: A modification important in the pathogenesis of autoimmune diseases
Dongwei Zhu, Song Wei, Zehui Jiang, et al.
Clinical Immunology (2022) Vol. 245, pp. 109134-109134
Closed Access | Times Cited: 15

IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
Hao Li, George C. Tsokos
Clinical Reviews in Allergy & Immunology (2020) Vol. 60, Iss. 1, pp. 31-45
Open Access | Times Cited: 21

The role of P2X7 receptor in infection and metabolism: Based on inflammation and immunity
Xiaoyu Cai, Yao Yao, Fei Teng, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108297-108297
Closed Access | Times Cited: 20

Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine
Patrícia Teixeira Santana, Isadora Schmukler de Lima, Karen Cristina da Silva e Souza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10874-10874
Open Access | Times Cited: 2

Transcriptome sequencing reveals novel molecular features of SLE severity
Xiaojing Zhang, Jiali Zhang, Zhaobing Pan, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6

Gut Microbiome and Circadian Interactions with Platelets Across Human Diseases, including Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Cancer
George Anderson
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 28, pp. 2699-2719
Closed Access | Times Cited: 6

Immunosuppression characterized by increased Treg cell and IL-10 levels in benzene-induced hematopoietic toxicity mouse model
Jiawei Huang, Kai Xu, Linling Yu, et al.
Toxicology (2021) Vol. 464, pp. 152990-152990
Closed Access | Times Cited: 12

P2 Receptors: Novel Disease Markers and Metabolic Checkpoints in Immune Cells
Valentina Vultaggio-Poma, Francesco Di Virgilio
Biomolecules (2022) Vol. 12, Iss. 7, pp. 983-983
Open Access | Times Cited: 8

P2X7 receptors: a bibliometric review from 2002 to 2023
Haiting Tang, Wei Wei, Yu Luo, et al.
Purinergic Signalling (2024)
Closed Access | Times Cited: 1

Immune Response Studies Based on P2X7 Receptors: A Mini-Review
Ying Deng, Mengting Zhou, Xingtao Zhao, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 12, pp. 993-999
Closed Access | Times Cited: 5

Association of P2X7 receptor genetic polymorphisms and expression with rheumatoid arthritis susceptibility in a sample of the Iranian population: a case-control study
Gholamreza Bahari, Farhad Tabasi, Mohammad Hashemi, et al.
Clinical Rheumatology (2021) Vol. 40, Iss. 8, pp. 3115-3126
Closed Access | Times Cited: 7

The P2X7 Receptor in Autoimmunity
Fabio Grassi, Gaia Salina
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14116-14116
Open Access | Times Cited: 2

P2X7 Receptor Expression and Signaling on Dendritic Cells and CD4+ T Cells is Not Required but Can Enhance Th17 Differentiation
Yin Yang, Meaghan E. Story, Xingxing Hao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4

P2X7 purinergic receptor plays a critical role in maintaining T-cell homeostasis and preventing lupus pathogenesis
Amine Mellouk, Tom Hutteau-Hamel, Julie Legrand, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4

Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome
Lili Li, Kimberly J. Jasmer, Jean M. Camden, et al.
Investigative Ophthalmology & Visual Science (2022) Vol. 63, Iss. 6, pp. 18-18
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top